HuGE Literature Finder
Records
1
-
30
| Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis. The Journal of pathology 2022 Jul . Kamp Eline Jca, Dinjens Winand Nm, Doukas Michail, van Marion Ronald, Verheij Joanne, Ponsioen Cyriel Y, Bruno Marco J, Groot Koerkamp Bas, Trivedi Palak J, Peppelenbosch Maikel P, de Vries Annemarie |
| [Prognosis after resection of intrahepatic cholangiocarcinoma: clinical significance of KRAS mutations]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2022 Feb . Schneider Martin A, Büchler M |
| Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.) 2022 Feb . Jeon Youngsic, Kwon So Mee, Rhee Hyungjin, Yoo Jeong Eun, Chung Taek, Woo Hyun Goo, Park Young Ny |
| Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
| Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Journal of gastrointestinal oncology 2021 Dec 12 (6): 2631-2642. Zheng Yuanwen, Qin Yejun, Gong Wei, Li Hongguang, Li Bin, Wang Yu, Chao Baoting, Zhao Shulei, Liu Luguang, Yao Shuzhan, Shi Junping, Shi Xiaoliang, Wang Kai, Xu Shife |
| Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. BMC cancer 2021 Feb 21 (1): 152. Xu Shifeng, Guo Yuan, Zeng Yanwu, Song Zhijian, Zhu Xiaodan, Fan Ning, Zhang Zhilei, Ren Guibing, Zang Yunjin, Rao W |
| Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
| Characteristics of genomic alterations in Chinese cholangiocarcinoma patients. Japanese journal of clinical oncology 2020 Jun . Jiang Guoping, Zhang Wu, Wang Ting, Ding Songming, Shi Xiaoliang, Zhang Shuirong, Shi Weiwei, Liu Angen, Zheng Shus |
| Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities. Hepatology (Baltimore, Md.) 2020 Jan . Goeppert Benjamin, Folseraas Trine, Roessler Stephanie, Kloor Matthias, Volckmar Anna-Lena, Endris Volker, Buchhalter Ivo, Stenzinger Albrecht, Grzyb Krzysztof, Grimsrud Marit M, Gornicka Barbara, von Seth Erik, Reynolds Gary M, Franke Andre, Gotthardt Daniel N, Mehrabi Arianeb, Cheung Angela, Verheij Joanne, Arola Johanna, Mäkisalo Heikki, Eide Tor J, Weidemann Sören, Cheville John C, Mazza Giuseppe, Hirschfield Gideon M, Ponsioen Cyriel Y, Bergquist Annika, Milkiewicz Piotr, Lazaridis Konstantinos N, Schramm Christoph, Manns Michael P, Färkkilä Martti, Vogel Arndt, , Boberg Kirsten M, Schirmacher Peter, Karlsen Tom |
| Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
| Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? HPB : the official journal of the International Hepato Pancreato Biliary Association 2019 May . Bagante Fabio, Ruzzenente Andrea, Conci Simone, Rusev Borislav C, Simbolo Michele, Campagnaro Tommaso, Pawlik Timothy M, Luchini Claudio, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
| ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass. Scientific reports 2018 Jul 8 (1): 10637. Jansen Ruben, Moehlendick Birte, Bartenhagen Christoph, Tóth Csaba, Lehwald Nadja, Stoecklein Nikolas H, Knoefel Wolfram T, Lachenmayer An |
| Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Human pathology 2018 Apr . Chi Zhikai, Bhalla Amarpreet, Saeed Omer, Cheng Liang, Curless Kendra, Wang Hanlin L, Patil Deepa T, Lin Jingm |
| Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma. Journal of the Formosan Medical Association = Taiwan yi zhi 2016 Oct . Huang Wen-Chih, Tsai Chien-Chen, Chan Chih-Chi |
| Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Histopathology 2016 Jul . Fujikura Kohei, Fukumoto Takumi, Ajiki Tetsuo, Otani Kyoko, Kanzawa Maki, Akita Masayuki, Kido Masahiro, Ku Yonson, Itoh Tomoo, Zen Y |
| Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas. American journal of clinical pathology 2016 Jun 145 (6): 815-25. Sasaki Motoko, Nitta Takeo, Sato Yasunori, Nakanuma Yasu |
| Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. Oncotarget 2016 Mar . Kim Young-Ho, Hong Eun-Kyung, Kong Sun-Young, Han Sung-Sik, Kim Seoung-Hoon, Rhee Je-Keun, Hwang Soo-Kyung, Park Sang-Jae, Kim Tae-M |
| Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. Annals of surgical oncology 2015 Dec . Ruzzenente Andrea, Fassan Matteo, Conci Simone, Simbolo Michele, Lawlor Rita T, Pedrazzani Corrado, Capelli Paola, D'Onofrio Mirko, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
| Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia. Human pathology 2015 Feb 46 (2): 202-9. Sasaki Motoko, Nitta Takeo, Sato Yasunori, Nakanuma Yasu |
| Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nature communications 2015 6 6120. Fujimoto Akihiro, Furuta Mayuko, Shiraishi Yuichi, Gotoh Kunihito, Kawakami Yoshiiku, Arihiro Koji, Nakamura Toru, Ueno Masaki, Ariizumi Shun-ichi, Nguyen Ha Hai, Shigemizu Daichi, Abe Tetsuo, Boroevich Keith A, Nakano Kaoru, Sasaki Aya, Kitada Rina, Maejima Kazihiro, Yamamoto Yujiro, Tanaka Hiroko, Shibuya Tetsuo, Shibata Tatsuhiro, Ojima Hidenori, Shimada Kazuaki, Hayami Shinya, Shigekawa Yoshinobu, Aikata Hiroshi, Ohdan Hideki, Marubashi Shigeru, Yamada Terumasa, Kubo Michiaki, Hirano Satoshi, Ishikawa Osamu, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Tsunoda Tatsuhiko, Nakagawa Hidewa |
| Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
| Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. Journal of gastroenterology and hepatology 2014 May 29 (5): 1119-25. Chang Yu-Ting, Chang Ming-Chu, Huang Kai-Wen, Tung Chien-Chih, Hsu Chiun, Wong Jau-M |
| Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Jan 27 (1): 73-86. Schlitter Anna Melissa, Born Diana, Bettstetter Marcus, Specht Katja, Kim-Fuchs Corina, Riener Marc-Oliver, Jeliazkova Petia, Sipos Bence, Siveke Jens T, Terris Benoit, Zen Yoh, Schuster Tibor, Höfler Heinz, Perren Aurel, Klöppel Günter, Esposito Ire |
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
| The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Human pathology 2013 Dec 44 (12): 2768-73. Robertson Scott, Hyder Omar, Dodson Rebecca, Nayar Suresh K, Poling Justin, Beierl Katie, Eshleman James R, Lin Ming-Tseh, Pawlik Timothy M, Anders Robert |
| KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer 2013 May 119 (9): 1669-74. Hsu Maylee, Sasaki Motoko, Igarashi Saya, Sato Yasunori, Nakanuma Yasu |
| Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Human pathology 2013 Feb . Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR |
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 Jan . Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM |
| Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies. Cancer 2012 Dec 118 (24): 6144-51. Kurzrock Razelle, Goel Sanjay, Wheler Jennifer, Hong David, Fu Siqing, Rezai Keyvan, Morgan-Linnell Sonia K, Urien Saik, Mani Sridhar, Chaudhary Imran, Ghalib Mohammed H, Buchbinder Aby, Lokiec François, Mulcahy Ma |
| Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: